Department of Psychology, University of Houston, Houston, TX, USA.
Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Cogn Behav Ther. 2022 Jul;51(4):326-342. doi: 10.1080/16506073.2021.2007995. Epub 2022 Jan 7.
74Distress tolerance (DT; perceived or actual ability to tolerate aversive physical or emotional states) is related to both posttraumatic stress disorder (PTSD) symptoms and substance use disorders (SUD). This investigation evaluates self-report and behavioral measures of DT as potential predictors of PTSD and SUD cognitive-behavioral therapy outcomes. Participants included 41 treatment-seeking adults (53.7% women; 73.2% African American; = 44.90, = 9.68) who met at least four symptoms of PTSD and substance dependence, assessed via structured interviews. At baseline (pre-treatment), participants completed the Distress Tolerance Scale (DTS), Mirror-Tracing Persistence Task (MTPT), Breath Holding task, and Paced Auditory Serial Addition Task. The Clinician-Administered PTSD Scale for DSM-5 severity scores and percent days of primary substance use, measured via Timeline Follow-back, were used as indicators of PTSD symptoms and substance use, respectively. Covariates included treatment condition, baseline PTSD symptom severity, and baseline substance use. Lower perceived DT at baseline (DTS total score) was associated with higher PTSD symptom severity at end-of-treatment. Lower behavioral DT at baseline (MTPT duration) was associated with higher substance use at the conclusion of treatment (i.e. proportion of number of use days to total number of days between two final treatment sessions).
74 耐受力(DT;感知或实际耐受痛苦的身体或情绪状态的能力)与创伤后应激障碍(PTSD)症状和物质使用障碍(SUD)有关。这项研究评估了 DT 的自我报告和行为测量作为 PTSD 和 SUD 认知行为治疗结果的潜在预测因素。参与者包括 41 名寻求治疗的成年人(53.7%为女性;73.2%为非裔美国人;=44.90,=9.68),他们通过结构访谈至少符合 PTSD 和物质依赖的四项症状标准。在基线(治疗前),参与者完成了痛苦耐受力量表(DTS)、镜像追踪持续任务(MTPT)、屏气时间和定时听觉连续加法任务。使用临床医生管理的 DSM-5 PTSD 严重程度量表和通过时间线回溯测量的主要物质使用天数百分比作为 PTSD 症状和物质使用的指标。协变量包括治疗条件、基线 PTSD 症状严重程度和基线物质使用。基线时感知到的 DT 较低(DTS 总分)与治疗结束时 PTSD 症状严重程度较高相关。基线时行为 DT 较低(MTPT 持续时间)与治疗结束时物质使用较高相关(即使用天数与两次最终治疗之间总天数的比例)。